Article O O O O
Text O O O O
Statistics O O O O
from O O O O
Altmetric.com O O O O
Request O O O O
Permissions O O O O
If O O O O
you O O O O
wish O O O O
to O O O O
reuse O O O O
any O O O O
or O O O O
all O O O O
of O O O O
this O O O O
article O O O O
please O O O O
use O O O O
the O O O O
link O O O O
below O O O O
which O O O O
will O O O O
take O O O O
you O O O O
to O O O O
the O O O O
Copyright O O O O
Clearance O O O O
Center's O O O O
RightsLink O O O O
service. O O O O
You O O O O
will O O O O
be O O O O
able O O O O
to O O O O
get O O O O
a O O O O
quick O O O O
price O O O O
and O O O O
instant O O O O
permission O O O O
to O O O O
reuse O O O O
the O O O O
content O O O O
in O O O O
many O O O O
different O O O O
ways. O O O O
After Reason 5 O O
millions Reason 5 O O
of Reason 5 O O
deaths Reason 5 O O
worldwide Reason 5 O O
and Reason 5 O O
months Reason 5 O O
of Reason 5 O O
widespread Reason 5 O O
social Reason 5 O O
and Reason 5 O O
economic Reason 5 O O
devastation, Reason 5 O O
the Reason 5 O O
first Reason 5 O O
vaccine Reason 5 O O
against Reason 5 O O
SARS-CoV-2 Reason 5 O O
(COVID-19) Reason 5 O O
was Reason 5 O O
given Reason 5 O O
emergency Reason 5 O O
use Reason 5 O O
listing Reason 5 O O
by Reason 5 O O
the Reason 5 O O
WHO.1 Reason 5 O O
Approved Reason 5 O O
only Reason 5 O O
1 Reason 5 O O
year Reason 5 O O
after Reason 5 O O
the Reason 5 O O
virus Reason 5 O O
was Reason 5 O O
first Reason 5 O O
identified Reason 5 O O
in Reason 5 O O
Wuhan, Reason 5 O O
China, Reason 5 O O
this Reason 5 O O
historic Reason 5 O O
achievement Reason 5 O O
was Reason 5 O O
the Reason 5 O O
result Reason 5 O O
of Reason 5 O O
public Reason 5 O O
and Reason 5 O O
private Reason 5 O O
institutional Reason 5 O O
partnerships, Reason 5 O O
as Reason 5 O O
well Reason 5 O O
as Reason 5 O O
decades Reason 5 O O
of Reason 5 O O
foundational Reason 5 O O
scientific Reason 5 O O
research. Reason 5 O O
Two Reason 5 O O
of Reason 5 O O
the Reason 5 O O
earliest Reason 5 O O
vaccines Reason 5 O O
authorised Reason 5 O O
for Reason 5 O O
widespread Reason 5 O O
use Reason 5 O O
were Reason 5 O O
the Reason 5 O O
BNT162b2 Reason 5 O O
(Pfizer/BioNTech) Reason 5 O O
and Reason 5 O O
mRNA-1273 Reason 5 O O
(Moderna) Reason 5 O O
messenger Reason 5 O O
RNA Reason 5 O O
(mRNA) Reason 5 O O
vaccines, Reason 5 O O
demonstrating Reason 5 O O
95% Reason 5 O O
and Reason 5 O O
94.1% Reason 5 O O
efficacy, Reason 5 O O
respectively, Reason 5 O O
in Reason 5 O O
phase Reason 5 O O
II/III Reason 5 O O
clinical Reason 5 O O
trials. Reason 5 O O
Notably, Reason 5 O O
both Reason 5 O O
vaccines Reason 5 O O
have Reason 5 O O
strong Reason 5 O O
safety Reason 5 O O
profiles, Reason 5 O O
with Reason 5 O O
the Reason 5 O O
most Reason 5 O O
common Reason 5 O O
adverse Reason 5 O O
events Reason 5 O O
including Reason 5 O O
injection Reason 5 O O
site Reason 5 O O
reactions, Reason 5 O O
fever, Reason 5 O O
chills, Reason 5 O O
fatigue, Reason 5 O O
headache, Reason 5 O O
and Reason 5 O O
muscle Reason 5 O O
and Reason 5 O O
joint Reason 5 O O
aches.2 Reason 5 O O
3 Reason 5 O O
Postauthorisation Reason 5 O O
reports Reason 5 O O
of Reason 5 O O
severe Reason 5 O O
reactions, Reason 5 O O
including Reason 5 O O
anaphylaxis, Reason 5 O O
have Reason 5 O O
been Reason 5 O O
extremely Reason 5 O O
rare, Reason 5 O O
occurring Reason 5 O O
in Reason 5 O O
only Reason 5 O O
4.5 Reason 5 O O
reported Reason 5 O O
cases Reason 5 O O
per Reason 5 O O
million Reason 5 O O
doses.4 Reason 5 O O
In O O O O
this O O O O
issue O O O O
of O O O O
Thorax, O O O O
Park O O O O
and O O O O
colleagues5 O O O O
present O O O O
the Reason 2 O O
first Reason 2 O O
published Reason 2 O O
case Reason 2 O O
of Reason 2 O O
COVID-19 Reason 2 O O
vaccine-related Reason 2 O O
interstitial Reason 2 O O
lung Reason 2 O O
disease Reason 2 O O
(ILD). Reason 2 O O
An Reason 2 O O
86-year-old Reason 2 O O
man Reason 2 O O
developed Reason 2 O O
an Reason 2 O O
acute Reason 2 O O
onset Reason 2 O O
of Reason 2 O O
fever, Reason 2 O O
weakness, Reason 2 O O
shortness Reason 2 O O
of Reason 2 O O
breath Reason 2 O O
and Reason 2 O O
hypoxaemia Reason 2 O O
requiring Reason 2 O O
high-flow Reason 2 O O
nasal Reason 2 O O
cannula Reason 2 O O
1 Reason 2 O O
day Reason 2 O O
after Reason 2 O O
receiving Reason 2 O O
a Reason 2 O O
dose Reason 2 O O
of Reason 2 O O
a Reason 2 O O
COVID-19 Reason 2 O O
mRNA Reason 2 O O
vaccine. Reason 2 O O
He Reason 2 O O
had Reason 2 O O
no Reason 2 O O
history Reason 2 O O
of Reason 2 O O
ILD, Reason 2 O O
connective Reason 2 O O
tissue Reason 2 O O
... Reason 2 O O
[View O O O O
Full O O O O
Text](https://thorax.bmj.com/content/77/1/9.full) O O O O
Footnotes O O O O
Twitter O O O O
@ericafarrandMD O O O O
Contributors O O O O
AMD O O O O
drafted O O O O
the O O O O
initial O O O O
version O O O O
of O O O O
the O O O O
manuscript, O O O O
and O O O O
AMD O O O O
and O O O O
EF O O O O
participated O O O O
in O O O O
drafting O O O O
all O O O O
revisions. O O O O
Both O O O O
authors O O O O
approved O O O O
the O O O O
final O O O O
manuscript O O O O
submitted O O O O
for O O O O
publication. O O O O
Funding O O O O
The O O O O
authors O O O O
have O O O O
not O O O O
declared O O O O
a O O O O
specific O O O O
grant O O O O
for O O O O
this O O O O
research O O O O
from O O O O
any O O O O
funding O O O O
agency O O O O
in O O O O
the O O O O
public, O O O O
commercial O O O O
or O O O O
not-for-profit O O O O
sectors. O O O O
Competing O O O O
interests O O O O
None O O O O
declared. O O O O
Provenance O O O O
and O O O O
peer O O O O
review O O O O
Commissioned; O O O O
externally O O O O
peer O O O O
reviewed. O O O O
Linked O O O O
Articles O O O O
Read O O O O
the O O O O
full O O O O
text O O O O
or O O O O
download O O O O
